Repro-Med Systems Granted FDA Approval For FREEDOM Integrated Syringe Infusion System
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K200176
91 Biggest Movers From Yesterday
Gainers
NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart stores nationwide.
54 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares gained 42.6% to $9.68. Pioneer Power Solutions recently announced the launch of its E-Boost portfolio of mobile Electric Vehicle charging solutions for a full range of applications.
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
48 Biggest Movers From Yesterday
Gainers
Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO and Chairman and announced the appointment of Yilin Wang as CEO.
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 7)
Repro-Med Systems: Q2 Earnings Insights
Shares of Repro-Med Systems (NASDAQ:KRMD) decreased 2.2% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share decreased 200.00% year over year to ($0.02), which were in line with the estimate of ($0.02).